Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model by Van Den Abbeele, Pieter et al.
University of Wollongong 
Research Online 
Faculty of Engineering and Information 
Sciences - Papers: Part A 
Faculty of Engineering and Information 
Sciences 
1-1-2013 
Butyrate-producing Clostridium cluster XIVa species specifically colonize 
mucins in an in vitro gut model 
Pieter Van Den Abbeele 




Ghent University, Belgium 
Michiel Kleerebezem 
Wageningen University 
William M. De Vos 
Wageningen University 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/eispapers 
 Part of the Engineering Commons, and the Science and Technology Studies Commons 
Recommended Citation 
Van Den Abbeele, Pieter; Belzer, Clara; Goossens, Margot; Kleerebezem, Michiel; De Vos, William M.; Thas, 
Olivier; De Weirdt, Rosemarie; Kerckhof, Frederiek-Maarten; and Van De Wiele, Tom, "Butyrate-producing 
Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model" (2013). Faculty of 
Engineering and Information Sciences - Papers: Part A. 1343. 
https://ro.uow.edu.au/eispapers/1343 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins 
in an in vitro gut model 
Abstract 
The human gut is colonized by a complex microbiota with multiple benefits. Although the surface-
attached, mucosal microbiota has a unique composition and potential to influence human health, it 
remains difficult to study in vivo. Therefore, we performed an in-depth microbial characterization (human 
intestinal tract chip (HITChip)) of a recently developed dynamic in vitro gut model, which simulates both 
luminal and mucosal gut microbes (mucosal-simulator of human intestinal microbial ecosystem (M-
SHIME)). Inter-individual differences among human subjects were confirmed and microbial patterns 
unique for each individual were preserved in vitro. Furthermore, in correspondence with in vivo studies, 
Bacteroidetes and Proteobacteria were enriched in the luminal content while Firmicutes rather colonized 
the mucin layer, with Clostridium cluster XIVa accounting for almost 60% of the mucin-adhered 
microbiota. Of the many acetate and/or lactate-converting butyrate producers within this cluster, 
Roseburia intestinalis and Eubacterium rectale most specifically colonized mucins. These 16S rRNA 
gene-based results were confirmed at a functional level as butyryl-CoA:acetate-CoA transferase gene 
sequences belonged to different species in the luminal as opposed to the mucin-adhered microbiota, with 
Roseburia species governing the mucosal butyrate production. Correspondingly, the simulated mucosal 
environment induced a shift from acetate towards butyrate. As not only inter-individual differences were 
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ORIGINAL ARTICLE
Butyrate-producing Clostridium cluster XIVa species
specifically colonize mucins in an in vitro gut model
Pieter Van den Abbeele1, Clara Belzer2, Margot Goossens1, Michiel Kleerebezem2,
Willem M De Vos2, Olivier Thas3,4, Rosemarie De Weirdt1, Frederiek-Maarten Kerckhof1
and Tom Van de Wiele1
1Laboratory of Microbial Ecology and Technology (LabMET), Ghent University, Ghent, Belgium; 2Laboratory
of Microbiology, Wageningen University, Wageningen, The Netherlands; 3Department of Mathematical
Modelling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium and 4Centre for Statistical and
Survey Methodology, School of Mathematics and Applied Statistics, University of Wollongong, Wollongong,
NSW, Australia
The human gut is colonized by a complex microbiota with multiple benefits. Although the surface-
attached, mucosal microbiota has a unique composition and potential to influence human health, it
remains difficult to study in vivo. Therefore, we performed an in-depth microbial characterization
(human intestinal tract chip (HITChip)) of a recently developed dynamic in vitro gut model, which
simulates both luminal and mucosal gut microbes (mucosal-simulator of human intestinal microbial
ecosystem (M-SHIME)). Inter-individual differences among human subjects were confirmed and
microbial patterns unique for each individual were preserved in vitro. Furthermore, in correspon-
dence with in vivo studies, Bacteroidetes and Proteobacteria were enriched in the luminal content
while Firmicutes rather colonized the mucin layer, with Clostridium cluster XIVa accounting for
almost 60% of the mucin-adhered microbiota. Of the many acetate and/or lactate-converting butyrate
producers within this cluster, Roseburia intestinalis and Eubacterium rectale most specifically
colonized mucins. These 16S rRNA gene-based results were confirmed at a functional level as
butyryl-CoA:acetate-CoA transferase gene sequences belonged to different species in the luminal
as opposed to the mucin-adhered microbiota, with Roseburia species governing the mucosal
butyrate production. Correspondingly, the simulated mucosal environment induced a shift from
acetate towards butyrate. As not only inter-individual differences were preserved but also because
compared with conventional models, washout of relevant mucin-adhered microbes was avoided,
simulating the mucosal gut microbiota represents a breakthrough in modeling and mechanistically
studying the human intestinal microbiome in health and disease. Finally, as mucosal butyrate
producers produce butyrate close to the epithelium, they may enhance butyrate bioavailability,
which could be useful in treating diseases, such as inflammatory bowel disease.
The ISME Journal (2013) 7, 949–961; doi:10.1038/ismej.2012.158; published online 13 December 2012
Subject Category: Microbe-microbe and microbe-host interactions
Keywords: bowel; Lachnospiraceae; Ruminococcaceae; Anaerostipes caccae; Faecalibacterium
prausnitzii; mucus
Introduction
The human colon is colonized by a complex
microbiota, mostly (490%) consisting of Bacteroi-
detes and Firmicutes (Eckburg et al., 2005; Claesson
et al., 2011; Walker et al., 2011). Beneficial con-
tributions of this microbiota to human health
include the breakdown of otherwise indigestible
food compounds (Koropatkin et al., 2012) and
regulation of host metabolism (Backhed et al.,
2005). Furthermore, the importance of the intestinal
mcrobiota follows from the number of diseases that
have been correlated with a dysbiosed microbial
composition, such as inflammatory bowel diseases
(IBDs; Willing et al., 2009; Walker et al., 2011) or
obesity (Turnbaugh et al., 2006). A novel focus in gut
microbiology is to not only study microbes in the
intestinal content but also those that colonize the
mucus layer (Swidsinski et al., 2008; Van den
Abbeele et al., 2011c; Belzer and de Vos, 2012).
The rationale is that mucosal microbes can interact
more closely with the epithelium than their
luminal counterparts, which may be crucial for
achieving immunomodulatory effects. Moreover, by
locally excreting antimicrobials or competing with
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pathogens, mucosal microbes more effectively limit
pathogen translocation. Besides host immune effec-
tors (Lievin-Le Moal and Servin, 2006), microbial
properties, such as mucus adhesion (Roos and
Jonsson, 2002) or the ability to degrade host-derived
glycans (Derrien et al., 2004), also impact the
distinct surface-attached microbial composition,
generally characterized by an enrichment of Firmi-
cutes (especially Clostridium cluster XIVa) over
Bacteroidetes (Eckburg et al., 2005; Frank et al.,
2007; Hill et al., 2009; Shen et al., 2010; Willing
et al., 2010; Hong et al., 2011; Nava et al., 2011).
Moreover, the mucus layer is persistently colonized
by all types of hydrogenotrophs: methanogenic
archaea, sulphate-reducing bacteria and acetogenic
bacteria (Nava et al., 2012).
Despite their physiological relevance, human
studies are often limited to faecal samples, which
do not provide information on this mucosal micro-
biota. For this purpose, biopsies need to be col-
lected, but given the invasive sampling procedures,
these are often only taken at the end of an
experiment, preventing dynamic monitoring or
detailed mechanistic studies (Zoetendal et al.,
2002). By contrast, in vitro studies have the
advantage that they are well-suited to perform
mechanistic research. However, the current models
generally only provide short-term information and
often ignore the interaction between luminal and
mucosal microbes. Recently, a long-term dynamic
in vitro model was developed, which accounts for
both the luminal and mucosal microbiota (mucosal-
simulator of human intestinal microbial ecosystem
(M-SHIME); Van den Abbeele et al., 2011b). The
simulated mucosal environment consisted of carrier
material coated with commercial pig gastric mucins.
When focussing on Lactobacilli, it was found that,
in correspondence with in vivo data, this in vitro
mucosal environment was colonized by specific
Lactobacillus species (L. mucosae and L. rhamnosus
GG). However, the overall microbial community
shifts remain to be elucidated.
Therefore, the aim of this study was to perform an
in-depth analysis of the in vitro mucosal M-SHIME
microbiota using the human intestinal tract chip
(HITChip), a recently developed and widely used
phylogenetic micro-array (Jonkers et al., 2009;
Rajilic-Stojanovic et al., 2009; Van den Abbeele
et al., 2011a). Each experiment was conducted with
samples from different human subjects to account
for the inter-individual variability. The aims were to
determine whether the inter-individual differences
among human subjects can be preserved in the
model, to determine the distinct composition of the
mucosal microbiota compared with the luminal one
and to assess the main metabolic activities of
mucosal microbes. By comparing these results with
recent in vivo data and results obtained with
conventional in vitro models without surface-
attached bacteria, the novel M-SHIME model was
validated.
Materials and methods
Chemicals and preparation of growth media
Unless stated otherwise, chemicals were obtained
from Sigma (Bornem, Belgium). The experiments
were conducted using sugar-depleted nutritional
medium containing (in g l 1) yeast extract (3.0),
peptone (1.0), commercial pig gastric mucin (4.0)
and cystein (0.5). Pancreatic juice contained (in
g l 1) NaHCO3 (12.5), bile salts (6.0; Difco, Bierbeek,
Belgium) and pancreatin (0.9). Mucin agar was
prepared by boiling dH2O containing 5% commer-
cial pig gastric mucin and 1% agar. The pH was
adjusted to 6.8 with 10 M NaOH.
Dynamic in vitro gut model for the luminal and
mucosal microbiota (M-SHIME)
Although the conventional luminal (L)-SHIME
(registered trademark, Ghent University-Prodigest,
Ghent, Belgium) only simulates luminal microbes (Van
den Abbeele et al., 2010), the M-SHIME also contains a
niche for surface-attached microbes (Figure 1a; Van den
Abbeele et al., 2011b). Briefly, microcosms (K1-carrier,
AnoxKaldnes AB, Lund, Sweden) were submerged in
mucin agar and combined in a polyethylene netting
(Zakkencentrale, Rotterdam, The Netherlands). At the
start of each experiment, 500ml nutritional medium
and 100 mucin-covered microcosms were added to each
colon unit, followed by inoculation with 40ml of a 1:5
dilution of fresh stools of a healthy human volunteer
(Possemiers et al., 2004). After an initial incubation of
18h, 140ml nutritional medium and 60ml pancreatic
juice were supplied to each colon compartment three
times per day. The M-SHIME was at 37 1C and kept
anaerobic by flushing twice per day for 15min with N2.
Based on earlier studies, several factors were
modified to optimally study mucin-adhered
microbes. (i) Long-term M-SHIME studies have
demonstrated that regular replacement of micro-
cosms, results in wash-out of mucin-adhered
microbes, probably due to limited cross-contamina-
tion between old and new microcosms (unpublished
results). Therefore, we performed short-term experi-
ments (3 days), which avoids renewal of micro-
cosms. (ii) Because such short-term studies are
confronted by a strong build-up of gasses and acids
due to fermentation of sugar-rich nutritional med-
ium, we used sugar-depleted medium, which
allowed a more moderate carbohydrate fermentation
upon inoculation. (iii) Thirdly, instead of operating
two SHIME units which each consist of an ascend-
ing, transverse and descending colon (Van den
Abbeele et al., 2010), we used the six colon vessels
as separate units allowing to test more conditions.
(iv) Finally, the pH of each unit was maintained
between 6.15 and 6.4 (Btransverse colon).
Experimental design
In the first/main experiment, the overall mucin-
adhered microbiota composition was characterized.
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Therefore, five M-SHIME units were inoculated
with stools of different human subjects: donor A
(male, 26 years), B (male, 33 years), C (male, 32
years), D (male, 24 years) and E (female, 32 years;
Figure 1a). Samples for short-chain fatty acid
(SCFA) analysis were collected after 18, 42 and
68 h. Samples of the inocula together with mucosal
and luminal samples of the final time point
(68 h) were snap-frozen in liquid nitrogen for micro-
bial characterization (denaturing gradient gel electro-
phoresis (DGGE), HITChip) and a clone library for the
butyryl-CoA:acetate-CoA transferase gene.
To validate results of this main experiment, two
additional experiments were performed. In the
second experiment, the contribution of mucosal
microbes to the overall microbial activity and
composition was evaluated. Therefore, three
M-SHIMEs (with mucosal environment) and three
L-SHIMEs (without mucosal environment) were
simultaneously inoculated with faecal inocula of
donors A, B and D (Supplementary Figure S1A). In
the third experiment, the impact of the presence of
mucins in the mucosal environment on mucosal
microbial activity and composition was evaluated.
Therefore, microcosms were coated with mucin-
containing or mucin-free agar. In this way, two colon
units with a mucosal environment containing
mucins (M(þ )-SHME), two colon units with a
mucosal environment free of mucins (M( )-SHME)
and two units without a mucosal environment
(L-SHIME) were inoculated with faecal samples of
donors A and D (Supplementary Figure S2A).
Samples for SCFA analysis were collected after 18,
42 and 68 h. Samples of the inocula together with
mucosal and luminal samples of the final time point
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Figure 1 (a) Schematic representation of the main/first experiment: five colon compartments with a simulated mucosal environment
(M-SHIME) were each inoculated with a different human faecal sample (donor A, B, C, D or E). (b) Dendrogram for the total bacterial
DGGE profiles of the luminal and mucosal microbiota of these five M-SHIMEs, 3 days after inoculation with faecal samples of five human
donors. The average inter-individual similarity between different donors (±s.e.m.) is shown for each type of sample: inoculum, lumen
and mucin layer.
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Microbial community (DGGE and HITChip) and
metabolic activity analysis (SCFA)
The most prominent shifts within the microbiota
were monitored via DGGE. After DNA extraction
(Boon et al., 2003) and PCR (Muyzer et al., 1993),
gels were run using an Ingeny PhorU apparatus
(Ingeny International, Goes, The Netherlands). Pear-
son correlation and UPGMA (Unweighted Pair Group
Method using Arithmetic Mean) clustering were used
to calculate dendrograms using BioNumerics v5.10
(Applied Maths, Sint-Martens-Latem, Belgium).
The HITChip was used for deep characterization of
the microbiota during the first/main experiment
(Rajilic-Stojanovic et al., 2009). The array contains
duplicated sets of 4800 16S rRNA oligonucleotide
probes targeting 1140 intestinal phylotypes (o98%
identity) and 131 genus-like groups (o90% identity).
Quantification of these groups has been validated
with fluorescence in situ hybridization, quantitative
PCR and 454 pyrosequencing (Rajilic-Stojanovic et al.,
2009; Claesson et al., 2011; van den Bogert et al., 2011).
Briefly, 16S rRNA genes were amplified, in vitro
transcribed, labelled with Cy3/Cy5 and hybridized to
the microarray, washed and scanned. Spot intensities
were extracted using Agilent Feature Extraction soft-
ware v9.5 and normalised using R-based scripts
(http://www.r-project.org/). Analysis were performed
in a custom-designed relational database, which runs
under MySQL database management system (http://
www.mysql.com/) using a series of custom R-scripts as
described previously (Rajilic-Stojanovic et al., 2009).
Acetate, propionate, butyrate, valerate, caproate
and branched SCFA (isobutyrate, isovalerate and
isocaproate) were measured as described previously
(De Weirdt et al., 2010).
Clone library for butyryl-CoA:acetate CoA-transferase
gene
DNA was amplified with primers BCoATscrF/
BCoATscrR (2.5 mM) (Louis and Flint, 2007). PCR
products were cut from a gel, purified (QIAquick Gel
Extraction Kit, QIAGEN, Antwerp, Belgium) and
cloned with a TOPO TA Cloning Kit with pCR2.1-
TOPO Vector (Invitrogen, Carlsbad, CA, USA). Clones
were amplified with primers M13F/M13R and
sequenced (AGOWA, Berlin, Germany). Sequences
(B480 bp) were manually inspected and compared
with databases at the NCBI website (http://blast.ncbi.
nlm.nih.gov/blast.cgi). Further, they were aligned
using the ClustalW algorithm with the ClustalW 1.6
weight matrix and a neighbour-joining tree with 2500
bootstrap iterations and the Kimura 2-parameter
substitution model was constructed (MEGA5), using
the 4-hydroxybutyrate CoA-transferase sequence from
A.caccae L1-92 as outgroup. Sequences with o98%
similarity to the 32 operational taxonomic units
(OTUs) described by Louis et al. (2010) were con-
sidered as novel OTUs. Sequences have been
submitted to the European Nucleotide Archive under
accession numbers HE984158–HE984296.
Statistics
All data were analyzed using SPSS16 (SPSS Inc.,
Chicago, IL, USA). Normality and homogeneity of
variances were studied with a Kolmogorov–Smirnov
and Levene test, respectively. If so, an analysis
of variance with Bonferroni test was performed
to investigate intergroup differences, otherwise a
Kruskal–Wallis with Mann–Whitney test was
applied.
A singular value decomposition was performed to
identify which factors most strongly determined the
microbial differences measured with the HITChip.
These factors consisted of three locations (faecal
inocula, lumen, mucin layer) and five sources
(donor A/B/C/D/E). The initial matrix X consisted
of 131 (¼ s) rows representing abundances of 131
genus-like groups and 15 (¼ t) columns representing
the 15 samples, being organized as follows: five
inocula, five luminal M- and five mucosal M-SHIME
samples, each time for donor A–E. Each column was
converted to ranks and this rank-transformed
matrix, XR, was decomposed in 15 terms each
consisting of a singular value (lj), vector uj (length s)
and vector vj




j . The 15 terms
are ordered so that l1Xl2XyXl15. Hence, the first
term is the most important in the approximation of XR,
the second term the second most important, and so on.
The significance of the contribution of location and
source was verified by applying analysis of variance
F-tests. Corresponding p-values (pL and pS) were
computed based on a Monte Carlo approximation of
the exact permutation null distributions.
To assess correlation of microbial groups detected
by HITChip with human inocula, mucin layer or
lumen, redundancy analysis was used as implemen-
ted in Canoco for Windows 4.5. Average signal
intensities for 131 genus-like groups were used as
microbial data, and diagrams were plotted using the
CanoDraw for Windows utility. The Monte Carlo
Permutation Procedure was used to assess statistical
significance of the variation in data sets in relation
to sample origin.
Results
In vitro mucosal environment enhances butyrate
production
SCFA were analyzed in the luminal content of
M-SHIME units of five different human subjects
(Figure 1a). As observed from the low standard
errors, SCFA levels were similar among individuals
(Table 1). Sixty-eight hours after inoculation, the
acetate/propionate/butyrate ratio of the M-SHIME
was 65/15/20, while for conventional models with-
out surface-attached bacteria such as the L-SHIME,
ratios of around 68/25/6 have been reported
(Van den Abbeele et al., 2010). Simulating the
mucosal environment thus seems to enhance
butyrate levels.
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Compared with the conventional L-SHIME, the
novel M-SHIME not only differed in the incorpora-
tion of a simulated mucosal environment but also in
a shorter incubation time, sugar-depleted nutritional
medium and a single-stage fermentation. To elim-
inate influence of the latter and straightforwardly
evaluate the impact of a mucosal environment, three
M-SHIME and three L-SHIME units were simulta-
neously inoculated with faeces of three donors
(Supplementary Figure S1A). It followed that from
the second day after inoculation onwards, the mucin
layer induced a proportional shift from acetate
( 6.3%) to butyrate (þ 3.9%) (Supplementary
Table S1). In a third experiment, the importance of
the presence of mucins in the mucosal environment
was evaluated (Supplementary Figure S2A). It
followed that the shift from acetate to butyrate was
more profound when the microcosms were coated
with mucin-containing as opposed to mucin-free
agar (only  2.6% acetate and þ 0.9% butyrate;
Supplementary Table S2).
Distinct microbial composition of human faeces, lumen
and mucin layer (DGGE)
To observe the main microbial shifts upon inocula-
tion of the M-SHIME, DGGE was performed on 16S
rRNA amplicons of the total bacterial community
(Figure 1b). The profiles were grouped as three
separate clusters according to sample origin: human
inocula, lumen and mucin layer. Based on the
Pearson correlation coefficients, it followed that
the mucin-adhered microbiota was very different
from the luminal microbiota (only 19±5% similar).
Furthermore, although similar shifts were observed
for the different human donors (Supplementary
Figure S3), there was significant inter-individual
variability among their faecal inocula (62±3%
similar), which continued to exist in the luminal
(64±5% similar) and mucin-adhered (44±7%
similar) M-SHIME microbiota.
Also the DGGE profiles of the second
(Supplementary Figure S1B) and third (Supple-
mentary Figure S2B) experiment revealed clustering
according to sample origin (inocula, lumen and
mucin layer) rather than to the donor
(Supplementary Figures S4 and S5). Both experi-
ments confirmed the distinct nature of the luminal
and mucosal communities (only 14±6% similar),
together with the inter-individual variability among
human inocula and resulting luminal and mucosal
microbiota. Both experiments also showed that the
luminal microbiota of the L- and M-SHIME are
highly similar (90±4% similar), suggesting that
the mucosal environment does not majorly affect
microbial composition in the luminal content
(Supplementary Figures S1B and S2B). From the
third experiment, it followed that the presence of
mucins in the mucosal environment is crucial for
the mucosal microbiota development. Although the
microbiota that colonized the mucin-free micro-
cosms was different from the luminal microbiota
(63±1% similar), the microbiota that colonized the
mucin-containing microcosms was much more dis-
tinct from the luminal microbiota (only 25±5%
similar; Supplementary Figure S2B).
In vitro gut model preserves the specific inter-
individual differences (HITChip)
In order to decipher the factors that influence
microbial colonization in the M-SHIME, a singular
value decomposition was applied on the high-
resolution phylogenetic HITChip data of the five
human inocula and five luminal and mucosal
M-SHIME samples. The first two terms in the
decomposition explained 39.6% and 28.4% of the
variation in the microbial dataset, caused by the
distinct microbial composition of the human
inocula, lumen and mucin layer (Table 2 and
Supplementary Figure S6). The next four terms also
explained a significant part of the microbial changes
(in total, 21.6%). Interestingly, these changes were
independent of the location but attributed to the
inter-individual differences among human subjects,
indicating that the individual-specific microbial
patterns are preserved in both the luminal and
mucosal M-SHIME environment.
Detailed characterization of luminal and mucosal
M-SHIME microbiota (HITChip)
Not only did the HITChip data confirm the distinct
microbial composition of the human inocula as
opposed to the lumen and mucin layer of the
M-SHIME (Supplementary Figure S7), it also pro-
vided a detailed phylogenetic characterization
(Figure 2 and Supplementary Table S3). The
Table 1 Average (±s.e.m.) absolute (mM) SCFA levels in the
luminal content of M-SHIME units during the first 3 days (18 h,
42 h and 68 h) after inoculation with faecal samples of five
different human donors (n¼5)
Time after inoculation 0 h 18 h 42 h 68 h
Absolute values (mM)
Acetate 7.7±1.5 36.5±1.4 31.1±1.1 31.3±0.5
Propionate 2.5±0.4 8.3±0.7 7.0±0.4 7.1±0.2
Butyrate 2.9±1.1 7.8±1.7 11.3±1.1 9.9±0.7
Valerate 0.6±0.1 1.9±1.1 2.4±0.9 1.6±0.6
Caproate 0.5±0.2 0.3±0.3 0.5±0.5 0.3±0.3
Branched SCFA 1.2±0.1 3.0±0.7 3.7±0.9 2.5±0.7
Total SCFA 15.4±3.2 57.9±3.7 56.0±3.2 52.9±1.7
Proportional values (mol%)
Acetate 50.8±1.2 63.6±2.2 56.0±2.4 59.5±2.1
Propionate 16.6±0.8 14.3±0.8 12.6±0.4 13.5±0.5
Butyrate 17.1±2.4 13.3±2.6 20.1±1.2 18.8±1.2
Valerate 4.0±0.4 3.0±1.7 4.1±1.4 2.9±1.1
Caproate 2.7±0.8 0.4±0.4 0.8±0.8 0.6±0.6
Branched SCFA 8.8±1.7 5.4±1.4 6.5±1.3 4.7±1.1
Abbreviations: M-SHIME, mucosal-simulator of human intestinal
microbial ecosystem; SCFA, short-chain fatty acid.
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Firmicutes phylum was significantly enriched in the
mucin layer (94% of the total community) as
opposed to the lumen (64%), attributed to increased
levels of Bacilli (3%) and bacteria belonging to the
Clostridium clusters I (10%), IV (19%), XI (2%) and
especially Clostridium cluster XIVa (59%). By
contrast, the mucin layer was virtually devoid of
Bacteroidetes (4%) and Proteobacteria (1%), which
rather colonized the luminal content (25% and 10%,
respectively).
Butyrate-producing bacteria from Clostridum cluster
XIVa colonize the mucin layer (HITChip)
A redundancy analysis of the HITChip data at the
bacterial group level (B131 genus-like groups)
confirmed the distinct microbiota of inocula, lumen
and mucin layer (P¼ 0.02; Figure 3a). Furthermore,
it specified the microbial changes as 68 genus-like
groups correlated with specific locations (Figure 3b
and Supplementary Table S4). Of these 68 groups,
15 specifically colonized the mucin layer (all
belonging to the Firmicutes), while 29 specifically
correlated to the lumen (21 belonging to the
Proteobacteria or Bacteroidetes). Finally, 24 bacter-
ial groups were equally abundant between
lumen and mucin layer but differed in abundance
compared with the inocula.
Several butyrate producers belonging to Clostri-
dium clusters IV and XIVa, but particularly the
latter, specifically colonized the mucosal M-SHIME
environment (Table 3). They include (expressed as
ratio of mucin-adhered/lumen) Roseburia intestina-
lis (84.3), Eubacterium rectale (38.9), Papillibacter
cinnamivorans (16.0), Eubacterium ventriosum
(15.3), Butyrivibrio crossotus (12.8), Faecalibacter-
ium prausnitzii (3.9), Clostridium orbiscidens (2.9)
and Coprococcus eutactus (2.9). By contrast, few
butyrate-producing groups specifically colonized
the lumen (expressed as ratio of lumen/mucin-
adhered): A. caccae (4.9), Subdoligranulum
variabile (2.7), Anaerotruncus colihominis (2.3)
and Clostridium symbiosum (1.4).
Clone library for butyryl-CoA:acetate CoA-transferase
gene confirms specific mucosal butyrate producers
Overall, 45% of the sequences of the butyryl-
CoA:acetate CoA-transferase gene belonged to
uncultured bacteria, with 16% of the sequences
belonging to novel butyrate-producing species
(OTU33–39). The 16S rRNA gene-derived results
(HITChip) were confirmed at a functional level as
the genes responsible for butyrate production were
carried by different microbes in the mucin-adhered
as opposed to the luminal microbiota (Figure 4).
Although Roseburia species and an unknown
species (OTU39) dominated the mucin-adhered
microbiota (R. intestinalis, R. hominis and
R. inulinvorans), the luminal butyrate producers
mainly consisted of strain M62-1 and related
unknown species (OTU24, 25 and 38). Five other
uncultured butyrate producers, (distantly) related to
Table 2 The singular value decomposition of the matrix
containing abundances of 131 genus-like groups (as determined
with the HITChip) of the human inocula, luminal and mucosal
M-SHIME samples (n¼5) resulted in six terms, which
significantly explained the variation in the data set caused by
either the location (¼human inoculum, lumen M-SHIME or
mucin layer M-SHIME) or source of the sample (¼human donor








1 0.0002 0.9492 39.6 Inoculum2M-SHIME
lumen/mucin layer
2 0.0000 0.9931 28.4 M-SHIME lumen2
M-SHIME mucin layer
3 0.8400 0.0008 8.4 Interindividual varia-
bility human inocula
4 0.9858 0.0205 5.6 Interindividual varia-
bility human inocula
5 0.6273 0.0371 4.5 Interindividual varia-
bility human inocula
6 0.9637 0.0242 3.1 Interindividual varia-
bility human inocula
Abbreviations: HITChip, human intestinal tract chip; M-SHIME,























Firmicutes = 94.4 % *
Figure 2 The average abundance (%) of higher taxonomic
groups (B phylum level) based on the HITChip analysis of the
human faecal inocula and the resulting luminal and mucosal
environment of the M-SHIME, 3 days after inoculation (n¼ 5). An
asterisks indicates a significant difference in the abundance
between the lumen and mucin layer of the M-SHIME. The
averages and s.e. can be found in Supplementary Table S3.
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Figure 3 (a) Redundancy analysis at genus-like group-level based on the HITChip data of the inoculum, lumen and mucin layer of
M-SHIMEs inoculated with faecal samples of five human subjects (n¼ 5; P¼0.02). (b) Dendrogram of the same samples based on the
HITChip data for 131 genus-like groups, including a heat map which shows the inter-individual distribution of microbial groups that
differed among inocula, lumen and/or mucin layer.
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F. prausnitzii, were also detected in the luminal
microbiota (OTU33–37).
Simulating a mucosal environment avoids wash-out of
surface-attached bacteria
The previously published HITChip data of a
conventional L-SHIME without mucosal environ-
ment (Van den Abbeele et al., 2010), showed that
this setup results in an enrichment of Bacteroidetes
and Proteobacteria and wash-out of Firmicutes
(Supplementary Figure S8). As the mucosal envir-
onment of the M-SHIME was specifically colonized
by Firmicutes members, especially belonging to the
Clostridium cluster XIVa, wash-out of these surface-
attached, mucosal Firmicutes is avoided (Figure 2).
This was further confirmed at the bacterial group
level, where HITChip analysis of the M-SHIME
microbiota also allowed characterizing bacterial
groups that rather colonized the mucin layer or
Table 3 The abundance (%) of butyrate-producing genus-like groups belonging to Clostridium clusters IV and XIVa (oFirmicutes) that
were significantly different between the luminal or mucosal M-SHIME environment, as determined with the HITChip (n¼ 5)
Bacterial group Inoculum Lumen Mucin layer
Clostridium cluster IV
Anaerotruncus colihominis 0.47±0.09a 1.94±0.30b 0.86±0.25a
Clostridium orbiscindens 1.49±0.21a 1.76±0.39a 5.17±0.86b
Faecalibacterium prausnitzii 10.92±1.20a 0.56±0.25b 2.20±0.50c
Papillibacter cinnamivorans 1.00± 0.21a 0.27±0.07b 4.31±0.73c
Subdoligranulum variabile 1.61±0.63a,b 2.53±0.43a 0.94±0.15b
Clostridium cluster XIVa
Anaerostipes caccae 0.15±0.05a 1.66±0.14b 0.34±0.06c
Butyrivibrio crossotus 1.58±0.53a 0.35±0.08b 4.48±1.00c
Clostridium symbiosum 1.83±0.32a 15.54±0.98b 10.95±0.22c
Coprococcus eutactus 1.73±0.21a 1.65±0.25a 4.83±0.72b
Eubacterium rectale 2.33±0.56a 0.22±0.06b 8.55±1.47c
Eubacterium ventriosum 0.78±0.21a 0.11±0.04b 1.68±0.27c
Roseburia intestinalis 1.62±0.49a 0.08±0.01b 6.74±0.59c
Abbreviations: HITChip, human intestinal tract chip; M-SHIME, mucosal-simulator of human intestinal microbial ecosystem.
aThe location (inoculum, lumen or mucin layer) with highest abundance was shaded with a darker background. Values with a different
superscript are significantly different (a, b or c).
Lumen Mucin layer















































Figure 4 Phylogenetic tree and the amount of butyryl-CoA:acetate-CoA transferase gene sequences (B480 bp) identified in the luminal
content and mucin layer of the M-SHIME 68 h after inoculation with human faecal samples of different donors (A, B and D; first
experiment). Sequences with at least 98% sequence identity were grouped together under the same OTU number of which one sequence
was chosen to build the phylogenetic tree. OTU numbers 432 indicate novel butyrate-producing species identified during the current
study.
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lumen. Although bacteria characterized as luminal
in the M-SHIME (Figure 5: area A) were maintained
at high levels in the conventional L-SHIME, those
characterized as mucosal in the M-SHIME (Figure 5:
area B) disappeared from the conventional
L-SHIME. Simulating a mucosal environment is
thus crucial for many Firmicutes species in order
to persist in an in vitro gut model.
Discussion
We recently developed the M-SHIME, an in vitro gut
model, which not only provides a niche for luminal
but also for surface-attached, mucosal microbes (Van
den Abbeele et al., 2011b). In this study, we confirm
the inter-individual differences in microbiota com-
position among different human stool and mucosal
samples (Zoetendal et al., 1998, 2002; Eckburg et al.,
2005) and demonstrate that these microbial patterns
unique to each individual are preserved in the
luminal and mucosal in vitro microbiota. A micro-
array with high phylogenetic resolution revealed the
unique composition of the in vitro mucosal micro-
biota in great detail.
The distinct microbial composition of the mucin
layer, lumen and faeces was the most determining
factor within the HITChip dataset accounting for
68% of the microbial differences, which was higher
than the variation caused by the inter-individual
differences among human subjects (21.6%; Table 2).
The Firmicutes phylum largely dominated the
mucosal M-SHIME microbiota (490%), with
Clostridium cluster XIVa species accounting for
60% of the total mucosal microbiota (Figure 2).
Concordant with the fact that this cluster includes
many acetate- and/or lactate-converting butyrate
producers, the simulation of a mucosal environment
induced a shift from acetate towards butyrate,
independent of the inoculum. Despite the fact that,
in living animals, the continuous desquamation of
mucus into the luminal content obscures the
distinction between luminal and mucosal microbes,
recent in vivo studies also show an enrichment of
Firmicutes (especially Clostridium cluster XIVa4
Lachnospiraceae family), over Bacteroidetes in
biopsies compared with luminal or faecal samples,
both in rodents (Hill et al., 2009; Nava et al., 2011)
and humans (Eckburg et al., 2005; Frank et al., 2007;
Shen et al., 2010; Wang et al., 2010; Willing et al.,
2010; Hong et al., 2011). This in vivo enrichment of
Firmicutes in mucus, although sometimes less
strong as during our in vitro study, suggests that
similar forces may drive the mucosal microbiota
composition in vivo and in vitro, likely to include
selection of specific groups that adhere to mucins
(Leitch et al., 2007) or insoluble substrates in
general (Walker et al., 2008). Furthermore, as
opposed to the luminal content where the pH was
maintained constant, local accumulation of acids in
mucus may cause a lower pH, selecting for Firmi-
cutes over Bacteroidetes and Proteobacteria (Duncan
et al., 2009). In addition, mucins may also serve as a
growth substrate for butyrate-producing Firmicutes,
possibly via cross-feeding with mucin-degrading
microbes that deliver partial breakdown products,
acetate and/or lactate (Belzer and de Vos 2012),
similar as reported for fructo-oligosaccharides
(Belenguer et al., 2006; Falony et al., 2006).
Independent of the underlying reason, the mucus
colonization by specific butyrate-producing Firmi-
cutes (especially Clostridium cluster XIVa) species
provides novel insight in the ecology of these
abundant human gut colonizers.
Although bacteria belonging to Clostridium clus-
ter XIVa, and to a lesser extent Clostridium cluster
IV, were enriched in the in vitro mucosal environ-
ment, some butyrate-producing bacterial groups
belonging to these clusters had higher abundances
in the luminal content (Table 3). The most specific
mucosal colonizers, as identified with the HITChip,
included R. intestinalis and E. rectale, while
A. caccae rather colonized the lumen. In contrast
to A. caccae that is non-motile, R. intestinalis and
E. rectale possess flagella, which may allow for
penetration into the mucus layer (Louis and Flint,
2009). Moreover, another difference is that the
mucosal butyrate producers solely require acetate
and no lactate for butyrate production (Louis and
Flint, 2009), indicating that cross-feeding with other
microbes might relate to the specific colonization of
mucus.
The selective mucus colonization by specific




























(log (abundance mucin layer M-SHIME/lumen M-SHIME))
Area A: luminal microbes Area B: mucosal microbes
Figure 5 Average abundance (%) of genus-like groups as
determined with the HITChip in a conventional L-SHIME without
simulation of the mucosal environment, as reported previously
(Van den Abbeele et al., 2010) (n¼4), as a function of the mucin
colonization of these microbes in the novel M-SHIME (n¼ 5).
Mucin colonization represents the preference of a bacterial group
to colonize the in vitro mucosal environment and is expressed as
the logarithm of the abundance in the mucosal environment
versus the abundance in the luminal content of the M-SHIME. A
value o0 indicates that the microbial group rather colonizes the
lumen (area A), a value 40 indicates that this group rather
colonizes the simulated mucosal environment (area B).
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interconnected with processes that affect the intest-
inal mucus as illustrated by two examples: con-
sumption of prebiotic compounds and IBD. Firstly,
prebiotics often enhance mucus production (Ten
Bruggencate et al., 2004; Van den Abbeele et al.,
2011a) and, according to our findings, this may
stimulate the release of mucosal butyrate producers
towards the lumen. This hypothesis is supported by
a study in which humanized rats were treated with
long-chain arabinoxylans or inulin (Van den
Abbeele et al., 2011a). Long-chain arabinoxylans
increased caecal mucin levels threefold, led to
higher butyrate levels and higher abundances of
butyrate producers, identified as mucosal butyrate
producers during this study (E. rectale and
R. intestinalis). Remarkably, inulin increased caecal
mucin levels by sixfold and corresponded with even
higher butyrate levels and higher abundances of the
same mucosal butyrate producers. Besides the
selective degradation of prebiotics by specific
butyrate producers (Duncan et al., 2002; Schwiertz
et al., 2002), stimulating mucus secretion may be a
mechanism by which prebiotics increase butyrate
levels. A second example is IBD, a disease in which
the mucus layer becomes thinner and more
discontinuous (Strugala et al., 2008). Recent
in vivo (Swidsinski et al., 2005; Sokol et al., 2008;
Walker et al., 2011) and in vitro (Vermeiren et al.,
2012) studies revealed that this disease correlates
with lower levels of mucosal butyrate producers,
including Roseburia and Faecalibacterium, indicat-
ing that a damaged mucus layer may lower the
ecological fitness of specific butyrate producers.
In vivo validation of the preference of butyrate
producers to reside in mucus together with
better understanding of factors that drive these
processes may allow to develop novel therapies.
As mucosal butyrate producers release butyrate
close to the epithelium, they may enhance butyrate
bioavailability for the host, which may be particu-
larly useful for IBD patients where transport
of butyrate to colonocytes is impaired (Thibault
et al., 2010).
The mucosal environment of the M-SHIME pre-
vents wash-out of microbes that disappeared from
conventional in vitro models (Figure 5). The enrich-
ment of Firmicutes over Bacteroidetes and Prote-
bacteria in the mucosal M-SHIME environment and
the fact that this contributes to higher butyrate levels
in the in vitro model further indicate that the
M-SHIME is a significantly improved simulation of
the intestinal microbiota compared with conven-
tional in vitro models. The latter models are indeed
confronted with lower abundances of Firmicutes,
especially butyrate-producing species belonging to
the Clostridium cluster XIVa and IV (Rajilić-
Stojanović et al., 2010; Van den Abbeele et al.,
2010), whereas Bacteroidetes and Proteobacteria are
very abundant (Allison et al., 1989; Macfarlane
et al., 1998; Mäkeläinen et al., 2009; Rajilić-
Stojanović et al., 2010; Van den Abbeele et al.,
2010), typically resulting in lower butyrate levels
(Allison et al., 1989; Van den Abbeele et al., 2010).
By avoiding washout of mucosal microbes, the
M-SHIME allows mechanistic studies that not only
focus on planktonic but also on surface-attached
microbes, increasing the relevance of in vitro
research.
Although meaningful results have been obtained
with the M-SHIME, several adaptations may further
enhance its value. Firstly, in order to obtain a large
surface area, one is currently limited to use
commercially available pig gastric mucins. These
mucins have lower molar mass averages and contain
more impurities than freshly prepared gastric
mucins (Jumel et al., 1996). Moreover, the composi-
tion of these gastric mucin (mainly MUC1, MUC5AC
and MUC6) differs from colonic mucins (mainly
MUC2) and changes in gastrointestinal diseases
(Reis et al., 1999; Corfield et al., 2000). In order to
improve the mucosal simulation in the M-SHIME,
more relevant mucins may be used in future
experiments. Ideally, human colonic mucins would
be coated on the carrier materials using an agar-
independent method. Next, Akkermansia mucini-
phila, the only known Verrucomicrobia representa-
tive that is a marker for mucin degradation (Belzer
and de Vos, 2012), did not attain high densities in
the current setup. Recent studies demonstrated that
Akkermansia degrades mucins in (distal) colon
regions characterized by depleted nutrient levels
and long residence times (Van den Abbeele et al.,
2010, 2011a). As colonization of mucus by different
mucolytic species may be crucial with respect to
human health (Png et al., 2010), the M-SHIME may
be improved by adding a distal colon region.
Further, for performing long-term experiments, a
setup needs to be designed in which mucin-covered
microcosms can be regularly renewed without
disturbing the stability of the mucosal and luminal
microbiota, particularly without opening the vessel
and exposing the micro-organisms to oxygen.
Finally, microbes are confronted with an oxygen
gradient in vivo as oxygen is continuously released
from the blood towards the mucus layer. Accounting
for this gradient would also add to the relevance of
the M-SHIME.
In conclusion, the recently developed M-SHIME
simulates not only planktonic but also surface-
attached gut microbes. In correspondence with
in vivo studies, the simulated mucosal environment
was specifically colonized by Firmicutes members,
including many butyrate producers of the Clostri-
dium cluster XIVa. Compared with conventional
in vitro models that do not account for surface-
attached microbes, wash-out of the latter species
was avoided resulting in a more in vivo-like
microbial composition and activity, allowing for
more relevant mechanistic in vitro studies to unravel
the importance of mucosal gut microbes in health
and disease. The M-SHIME may thus be an excellent
tool to isolate novel mucosal microbes and to
Clostridium cluster XIVa species colonize mucins
P Van den Abbeele et al
958
The ISME Journal
study factors that drive health-promoting or
disease-causing microbes to reside in the mucosal
microbiota from where they can closely interact
with the host epithelium. The potential to isolate
novel microbes was supported by the finding that
45% of the butyrate producers in the M-SHIME
belonged to uncultured species. In this context,
discovery of mucosal butyrate producers may lead to
a novel therapy for diseases such as IBD, which are
characterized by an impaired butyrate transport to
the colonocytes. Further, as the microbial patterns
unique to the five tested human subjects were
preserved in the in vitro model, the M-SHIME may
be used in future studies using larger cohorts to
focus on these inter-individual differences.
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